Dow Up 1.12% Nasdaq Up 2.08%

More On TRABI.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transgene Biotek Ltd. (TRABI.BO)

-BSE
4.73 Down 0.23(4.64%) 5:59AM EDT
Prev Close:4.96
Open:5.29
Bid:4.73
Ask:4.77
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:4.53 - 5.29
52wk Range:3.01 - 7.40
Volume:35,944
Avg Vol (3m):136,600
Market Cap:311.09M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

  • No Headlines available for TRABI.BO at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transgene Biotek Limited, a biopharmaceutical company, acquires, develops, and commercializes drugs and drug delivery platforms primarily to treat cancer in India. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback